Author

P. J. Winyard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Assay:scRNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. S. Woolf· 2 shared D. A. Long· 2 shared D. J. Jafree· 2 shared G. Pomeranz· 2 shared J. C. Chandler· 2 shared M. Kolatsi-Joannou· 2 shared S. Malik· 2 shared W. J. Mason· 2 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. S. Woolf

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 28, 2022

Three-dimensional imaging and single-cell transcriptomics of the human kidney implicate perturbation of lymphatics in alloimmunity

D. J. Jafree, B. Stewart, M. Kolatsi-Joannou…·D. A. Long

This study uses 3D imaging and single-cell RNA-sequencing to analyze human kidney lymphatics, revealing structural and transcriptional changes in rejecting kidney transplants.

DOI 10.1101/2022.10.28.514222

humanspatial transcriptomics

𝕏 PostBluesky

Cell BiologybioRxivPreprintOct 11, 2022

Exploration of the single-cell transcriptomic landscape identifies aberrant glomerular cell crosstalk in a murine model of WT1 kidney disease

J. C. Chandler, D. J. Jafree, S. Malik…·D. A. Long

This study uses single-cell RNA sequencing to identify disrupted cell-cell communication in a mouse model of WT1 kidney disease, highlighting non-immunological pathology and suggesting vascular-targeted therapies.

DOI 10.1101/2022.10.11.511555

mousescRNA-seq

𝕏 PostBluesky